Related references
Note: Only part of the references are listed.Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
Hui-Yan Luo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: Current evidence and future perspectives
Ana Custodio et al.
CANCER TREATMENT REVIEWS (2013)
Predictive Impact of Circulating Vascular Endothelial Growth Factor in Four Phase III Trials Evaluating Bevacizumab
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2013)
Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection
Fiona Collinson et al.
CLINICAL CANCER RESEARCH (2013)
Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology
Alice M. Turner et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Impact of Circulating Vitamin D Binding Protein Levels on the Association between 25-Hydroxyvitamin D and Pancreatic Cancer Risk: A Nested Case-Control Study
Stephanie J. Weinstein et al.
CANCER RESEARCH (2012)
Proteomic Characterization of Histotroph during the Preimplantation Phase of the Estrous Cycle in Cattle
Michael P. Mullen et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Vitamin D receptor gene polymorphisms and colorectal cancer risk: A systematic meta-analysis
Yong-Heng Bai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Vitamin D as a promising anticancer agent
Chandra Kanti Chakraborti
INDIAN JOURNAL OF PHARMACOLOGY (2011)
Vitamin D-Binding Protein Modifies the Vitamin D-Bone Mineral Density Relationship
Camille E. Powe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular Angiogenesis
Partha S. Bhattacharjee et al.
PLOS ONE (2011)
Interactions between Plasma Levels of 25-Hydroxyvitamin D, Insulin-Like Growth Factor (IGF)-1 and C-Peptide with Risk of Colorectal Cancer
Kana Wu et al.
PLOS ONE (2011)
Plasma 25-Hydroxyvitamin D Levels and the Risk of Colorectal Cancer: The Multiethnic Cohort Study
Christy G. Woolcott et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Alberto Bardelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Biomarkers to predict the clinical efficacy of bevacizumab in cancer
Adrian M. Jubb et al.
LANCET ONCOLOGY (2010)
Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells
Kalvin J. Gregory et al.
PLOS ONE (2010)
AmiGO: online access to ontology and annotation data
Seth Carbon et al.
BIOINFORMATICS (2009)
Angiotensinogen Delays Angiogenesis and Tumor Growth of Hepatocarcinoma in Transgenic Mice
Francois Vincent et al.
CANCER RESEARCH (2009)
Apolipoprotein E limits oxidative stress-induced cell dysfunctions in human adipocytes
Evelyne Tarnus et al.
FEBS LETTERS (2009)
Serum Proteomic Approach for the Identification of Serum Biomarkers Contributed by Oral Squamous Cell Carcinoma and Host Tissue Microenvironment
Krikor Bijian et al.
JOURNAL OF PROTEOME RESEARCH (2009)
2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer
Jennifer C. Byrne et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The multiplex bead array approach to identifying serum biomarkers associated with breast cancer
Byoung Kwon Kim et al.
BREAST CANCER RESEARCH (2009)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
被撤回的出版物: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF (Retracted article. See vol. 63, pg. 1349, 2014)
Nobuto Yamamoto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Epidermal growth factor receptor inhibitors in colorectal cancer treatment:: What's new?
M. Ponz-Sarvise et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Angiotensinogen impairs angiogenesis in the chick chorioallantoic membrane
Marcus Brand et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
1α,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells
Moshe Ben-Shoshan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism
Marijn Speeckaert et al.
CLINICA CHIMICA ACTA (2006)
Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen
Celine Bouquet et al.
MOLECULAR THERAPY (2006)
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men
E Giovannucci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Associations between apoE genotype and colon and rectal cancer
ML Slattery et al.
CARCINOGENESIS (2005)
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice
O Kisker et al.
NEOPLASIA (2003)
Cellular turnover in the rat uterine cervix and its relationship to estrogen and progesterone receptor dynamics
JG Ramos et al.
BIOLOGY OF REPRODUCTION (2002)
Share Paper
